1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine has been researched along with Pregnancy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, J; Chen, C; Chen, FY; Chu, C; Du, MF; Gao, K; Gao, WH; Guan, YJ; Hu, GL; Hu, JW; Jia, H; Li, CH; Liao, YY; Ma, Q; Mu, JJ; Niu, ZJ; Sun, Y; Wang, D; Wang, KK; Wang, X; Wang, Y; Yan, Y; Yang, TL; Yao, S; Zhang, J; Zhang, X; Zhang, XY; Zhou, HW; Zou, T | 1 |
1 other study(ies) available for 1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine and Pregnancy
| Article | Year |
|---|---|
Associations of plasma PAPP-A2 and genetic variations with salt sensitivity, blood pressure changes and hypertension incidence in Chinese adults.
Topics: Adult; Animals; Blood Pressure; Blood Proteins; China; Female; Humans; Hypertension; Incidence; Piperazines; Polymorphism, Single Nucleotide; Pregnancy; Rats; Sodium Chloride, Dietary | 2021 |